利伐沙班（CAS 366789-02-8）：分子式 C19H18ClN3O5S、分子量 435.9。
| CAS号 | 366789-02-8 |
|---|---|
| 分子式 | C19H18ClN3O5S |
| 分子量 | 435.9 |
| LogP | 2.5 |
| 应用领域 | Uses: MEDICATION、Anticoagulant、Methods of Manufacturing: Preparation: A. Straub et al.、World Intellectual Property Organization patent 0147919、eidem、United States of America patent 7157456 (2001、2007 both to Bayer)、Formulations、Preparations: Table: Rivaroxaban Preparations [Table#8112] |
登记用途：Uses: MEDICATION、Anticoagulant、Methods of Manufacturing: Preparation: A. Straub et al.、World Intellectual Property Organization patent 0147919、eidem、United States of America patent 7157456 (2001、2007 both to Bayer)、Formulations、Preparations: Table: Rivaroxaban Preparations [Table#8112]。
利伐沙班 是一种化工化合物，登记 CAS 号为 366789-02-8，分子式 C19H18ClN3O5S（分子量 435.9）。
登记 CAS 号：366789-02-8
其分子式 C19H18ClN3O5S 由 19 个碳、18 个氢、1 个氯、3 个氮、5 个氧、1 个硫 组成。
别名/同义词：利伐沙班 · Rivaroxaban
利伐沙班 的 CAS 登记号为 366789-02-8。
分子式 C19H18ClN3O5S，分子量 435.9。
别名/同义词：利伐沙班、Rivaroxaban。
登记用途：Uses: MEDICATION、Anticoagulant、Methods of Manufacturing: Preparation: A. Straub et al.、World Intellectual Property Organization patent 0147919、eidem、United States of America patent 7157456 (2001、2007 both to Bayer)、Formulations、Preparations: Table: Rivaroxaban Preparations [Table#8112]。
利伐沙班（CAS 366789-02-8）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 366789-02-8 |
|---|---|
| PubChem CID | 9875401 |
| Molecular formula | C19H18ClN3O5S |
| IUPAC name | 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide |
| UNII (FDA) | 9NDF7JZ4M3 |
| Molecular Weight | 435.9 |
|---|---|
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 435.0655696 |
| Monoisotopic Mass | 435.0655696 |
| Topological Polar Surface Area | 116 |
| Heavy Atom Count | 29 |
Rivaroxaban; 366789-02-8; Xarelto; BAY 59-7939; BAY59-7939; 9NDF7JZ4M3; BAY-59-7939; 5-Chloro-N-({(5s)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)phenyl]-1,3-Oxazolidin-5-Yl}methyl)thiophene-2-Carboxamide; JNJ39039039; JNJ-39039039; CHEBI:68579; B01AF01; 2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-; 5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl}thiophene-2-carboxamide; 2-Thiophenecarboxamide, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
| GHS notification summary | 1.2% (1 / 85) |
|---|
| GHS notification summary | 1.2% (1 / 85) |
|---|---|
| Reported hazard statements | H411 (89.4%) |
This chemical does not meet GHS hazard criteria for 1.2% (1 of 85) of reports.
H411 (89.4%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
Rivaroxaban · CAS 366789-02-8 · C19H18ClN3O5S. UNII 9NDF7JZ4M3.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Rivaroxaban